27,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
14 °P sammeln
  • Broschiertes Buch

In recent decades, Informed Consent (IC) has been established as a new right, which recognizes the autonomy of the subjects and grants the privilege to the patient's decisions, as it is the autonomous acceptance of a medical intervention, or the choice between possible alternative courses. In this sense, Informed Consent (IC) is the basis of health care activity in the diagnosis and treatment of patients. It is part of the rights in health, but also new duties, for professionals and for users. Informed Consent (IC) is not only circumscribed to Clinical Practice but also to the field of…mehr

Produktbeschreibung
In recent decades, Informed Consent (IC) has been established as a new right, which recognizes the autonomy of the subjects and grants the privilege to the patient's decisions, as it is the autonomous acceptance of a medical intervention, or the choice between possible alternative courses. In this sense, Informed Consent (IC) is the basis of health care activity in the diagnosis and treatment of patients. It is part of the rights in health, but also new duties, for professionals and for users. Informed Consent (IC) is not only circumscribed to Clinical Practice but also to the field of Teaching and Research, as we shall analyse in this text. Currently we are in the midst of the COVID Pandemic - 19 (Coronavirus), the context of Informed Consent has changed substantially since in extreme cases it is not possible to request and obtain it due to difficulties inherent in the circumstances and ethical dilemmas arise for the doctor in charge of the patient that must be resolved in a Medical Board or by the Healthcare Ethics Committee of the Health Centre.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Dr Javier Rubén Tovar Brandán, g¿ówny profesor Wydziäu Medycyny Cz¿owieka UNMSM. Tytu¿ magistra prawa zdrowotnego i bioetyki z UCLM. Studia magisterskie w dziedzinie rzadkich chorób, Uniwersytet w Walencji. Abg. Michael Zubiat Aguilar, prawnik, magister w dziedzinie zamówie¿ publicznych.